Ahmed Bennis/X
Nov 27, 2025, 05:00
LAAO vs. Anticoagulants․ What Works Best in ESRD Patients with AF?
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared on X:
”Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease.
In propensity-matched cohorts of ESRD patients with AF, the composite outcome of stroke or SE, MB, and all-cause mortality was higher in those treated with apixaban or warfarin compared with those who underwent LAAO.”
Read more here.
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 18:59Chokri Ben Lamine: Contributing to a Landmark Chapter on Amegakaryocytic Thrombocytopenia in Bone Marrow Failure
-
Apr 20, 2026, 18:39David McIntosh: A Watershed Moment for Global Plasma Community and Call for Unified Action
-
Apr 20, 2026, 18:15Nandini Pethe: Grateful for a Fantastic 2026 HFA Symposium Filled with Impactful Educational Sessions and Meaningful Connections
-
Apr 20, 2026, 17:13Armghan Ans: The Stroke Decision Nobody Owns
-
Apr 20, 2026, 17:12Assefa Desalew: RhD-Negative Status and Adverse Perinatal Outcomes in Eastern Ethiopia
-
Apr 20, 2026, 16:55Francesco Lo Monaco: Blood Type and Heart Risk – Small Differences, Bigger Role of Lifestyle
-
Apr 20, 2026, 16:44Supporting the Next Generation in Thrombosis and Hemostasis at ISTH 2026
-
Apr 20, 2026, 16:38Bjorn Logi Thorarinsson: Strengthening Stroke Units Through Certification, Registries, and Evidence-Based Practice
-
Apr 20, 2026, 16:37Domenico Girelli: Anemia Is Linked to Higher Dementia Risk and Elevated Alzheimer’s Disease Biomarkers